Market News

Yuhan Corporation to receive up to USD 870 million in upfront and success-based development and commercialization milestones, excluding royalties.

The space will support cGMP manufacturing of animal component-free, dry powder media, liquid media, and downstream bioprocessing liquids.

Demonstrates the unique ability of diffusional sizing to assess protein binding in-solution and for difficult-to-study systems.

Xiidra 5% is the first and only prescription treatment approved to treat both signs and symptoms of dry eye by inhibiting inflammation caused by the disease.

Public perception, however, still falls far below other sectors.

Designed for gentle stirring and optimum growth of cell lines.

New Thermo Scientific Cytomat 2 C-LiN Series Automated Incubator delivers robust and reliable culture solution for cell-based pharmaceutical applications.

Transaction will create a leading biopharmaceutical company with approximately $48 billion in combined 2019 revenue.

Kit provides all the key elements required to carry out an operator aseptic broth transfer test.

Ready-to-use immunoassay kit increases analytical output and productivity in bioprocess workflows.

Collaboration aims to change how Sanofi develops new treatments and will focus on to better understand patients and diseases, to increase Sanofi’s operational efficiency, and to improve the experience of Sanofi’s patients and customers.

Industry leaders give voice to issues and trends shaping the biotech sector, including the importance of collaboration.

A fully formulated one-step system providing simple preparation and ease-of-use for film coating.

Company can now offer an animal-free test method to quantify the strength of an allergenic effect.

Univercells' propriety bioproduction platform has already proven success.

Plant-expression deal for difficult to produce proteins, vaccines, metabolites and natural proteins.

PhoenixMD and WuXi STA have produced a multikilogram drug supply for PMD-026 under GMP manufacturing practices.

Funding will also be used to further expand operations in the UK and US.

PTC and Rockwell Automation combine technologies to accelerate customers’ digital transformation initiatives.

Owlstone Medical and IAHFIAW to use Breath Biopsy to examine the chemicals found on the breath of individuals with documented historical exposure to asbestos and radiologically and histologically confirmed mesothelioma.

Early-phase molecule from Centrexion to be developed further as a potential non-opioid treatment option for multiple pain conditions.

Additional three new reactor trains will help the CDMO to meet growing market demand for smaller API batch sizes.

Vibalogics will expand capabilities to meet rapidly growing demand for development and manufacturing of complex viral products.

One customer saves $25m and 3 years' development time in their clinical development strategy.

Inspiration, innovation and technical highlights from Bosch Packaging Technolgy's Pharmatag 2019.

All German sites of the pharmaceutical service provider will be supplied with green electricity.

Regulatory reforms and harmonisation reported as key drivers of industry in China.

Veratrak to help CPO achieve digitsied end-to-end visibility of its supply chain.

Now authorized to test, develop and manufacture cannabis-derived pharmaceutical materials.

WuXi STA will provide integrated CMC services from pre-clinical to commercial, for both API and formulation for Dizal Pharmaceutical research projects.

Acquisition of Paragon Bioservices brings specialized expertise in adeno-associated virus and will enhance Catalent’s biologics business and end-to-end integrated biopharmaceutical solutions for customers.

The European Commission has recently awarded VIO Chemicals with the Seal of Excellence, a high-quality label for first-class innovation ideas worthy of investment.

Company plans to double its operations in the country over the next 3 years and expand its work with local companies as well as continuing to support global multinationals.

Acquisition includes novel late-stage renal cell carcinoma candidate, PT2977.

Modules include a variety of subjects from an ’Introduction to tablet tooling’ and ‘Tooling maintenance’, to ‘Troubleshooting production problems’ and ‘Improving productivity’.

Delivering 2023 traceability by leveraging blockchain and digital recalls across a supply network.

2’-FL a very promising agent for digestive health across various age groups beyond infancy.

Increased manufacturing and packaging capacity and service in the UK allows company to better service growing client base in the US who require a fully outsourced supply chain for their products within Europe.

UAE consumers and insurance companies are willing to pay for highest quality drug products.

New starch-based excipient plays an important role in enhancing the stability of moisture-sensitive APIs.

The increase in biologics is driving the growth in demand for lyophilization in vials.

Data exchange, investment costs, resources and hardware identified as some of the biggest challenges.

Company is one of the first CDMOs to receive award.

Company has also invested in an Äkta-ready chromatography system for downstream processing and liquid handling equipment to deal with increased volumes.

Makes model data easier to interpret for better process control.

I Holland launches online training for all levels of pharmaceutical and nutraceutical professionals.

Offers a seamless outsourcing service for inhalation products, including MDIs, DPIs and nasal sprays.

$40 million investment adds spray drying, stick pack and expanded capabilities in controlled-release tableting and encapsulation.

Acquisition will help customers to shorten time-to-market of new drugs.

Will improve operational efficiency and drive faster, higher-quality trial execution.

Number of visitors seeking a contract manufacturer was extremely high, with multinational corporations increasingly looking for local partners to expedite market access into the wider region.

SSB's new generation of ambr 15 supports cell and gene therapy applications, including HEK293 for viral vector production, T-cells, iPSCs and other immune-derived cell lines.

Customers will receive comprehensive support particularly at the critical phases of industrial scale-up, technology transfer and process validation.

Using easy-to-apply cream instead of direct scalp injection would extend patent protection by 8 years.

Despite a delayed Brexit, unpredictability adds further complications to the EU FMD regulation.

Expansion includes two new softgel encapsulation lines dedicated to Catalent’s proprietary Vegicaps technology.

Provides a guide on all aspects of the subject with much of the information based on the systems, processes and expertise built up at MedPharm.

New equipment installations will include vial labellers, as well as an HPV cold sterilization system.

Eddingpharm to pick up Ceclor and Vancocin and manufacturing facility.

Patent-pending technology is the first ever to enable a softgel capsule to contain both probiotic bacteria and Omega 3 oil.

India predicted to be one of the world’s ‘fastest growing bio’ hubs in 2019, fuelled by new biosimilars production.

First-of-its-kind partnership recycles more than 55,200 pounds of contact lenses, blister packs and top foil in less than 3 years.

Legacy Pharmaceuticals uses SCHOTT Type I Plus vials to overcome a leaching issue.

Company's $4 million investment reflects market need for contract service providers who can provide innovative and cost-effective topical manufacturing capabilities for products that include highly potent actives.

Will provide new expertise and capabilities in one of the fastest-growing areas of healthcare.

The loan will be used to develop KERUS Cloud - currently the only software that can simulate trials with multiple correlated outcomes - by integrating it into an intelligent software ecosystem.

The Papillon DPI is a single-part, blister-based, reusable inhaler, suitable for both chronic and acute treatments.

The Aquacoat product line provides modified release drug profiles with the added benefit of global regulatory acceptance.

Initiative will enable Sirio Pharma to keep abreast of regional trends, new ingredients, dosage forms and claims to provide customers unique product ideas for line extensions.

Offers an alternative to cross-adsorbed secondary antibodies when absolute specificity is required.

New guidelines will see poorer quality manufacturers drop out of the market.

The acquisition will enhance the CDMO's chemistry development capabilities to support pre-clinical and early phase clinical supply.

Highway 1 addresses a major unmet need for improved cell-sorting technology, with applications including development of cell therapies, liquid biopsy diagnostics, and high-throughput drug discovery.

Lonza and Chr. Hansen create a strategic joint venture to become the partner of choice for developing and manufacturing live biotherapeutic products for pharma and biotech customers.

Company's hybrid solution claims superior performance compared with tradition single-use technologies.

The ingredients are extracted from the first organically certified rambutan gardens in Vietnam.

Investment will improve production cycle time and provide greater flexibility to customers.

Scientists to rapidly obtain detailed process understanding and control over their microbial cultures.

Global contract provider to develop new XF-platform drug formulations for the treatment of a number of topically treated infections, including diabetic foot ulcers and ophthalmic infections.

CDMO positioned to empower more customers to develop innovative drugs faster and more efficiently.

Generics consumption increasing, and the removal of long-list products is opening up funding towards true innovation.

The post-Brexit regulatory environment continues to weigh heavily on the minds of regulatory professionals.

Direct cellular conversion technology recognized at prestigious business awards.

The user’s guide to regulatory expectations, the testing process, what to do in the event of test failure, and more.

Expansion projects will increase capacity to meet growing customer demand for biologics.

A fully redundant supply of digoxin API from C2 Pharma will be available via two CMO manufacturing sources at Nobilus in Poland and Laurus Labs in India.

Patient-centricity, eco-friendly and smart packaging trends marked as the biggest growth drivers and innovations in 2019.

Aptar Pharma’s Bidose liquid system is designed for local or systemic delivery of drugs.

Future plan is to extend Sterling’s international presence to meet increasing demand from customers worldwide.

Pall and Broadley-James’ combined expertise proves complementary in addressing critical customer pain points in modern bioprocessing.

Event for experts from academia and industry, including talks, live demo sessions, and panel discussion.

End-to-end industrial production of innovative medical technology products.

Line of Sight approach to freeze-drying enables organizations to bring pharmaceutical products safely and quickly to market.

Optimally run membrane chromatography processes will provide higher productivity, smaller-scale operations and increased robustness.

Authorized generic version of Humalog will be available in US pharmacies at 50% lower list price.

Nightstar Therapeutics has two potentially first-in-class mid- to late-stage clinical assets as well as preclinical programs.

The availability of three new alternative switchable LED configurations provides chemists with the unique ability to optimally undertake almost any photochemistry reaction.

Connecting scientists, patients, and industry to advance drug development in a collaborative open market.

Executives predict Japan to be the second fastest growing mature market for solid dose drugs in 2019, and the second fastest overall country for biologicals growth.

ISO 45001 developed to improve employee safety, reduce workplace risk and create better working conditions globally.

2019 will mark Uniplast's debut at this year's edition of CPHI Worlwide in Frankfurt, where it will showcase its expertise in plastic packaging.

Healthcare and pharmaceutical reforms, designed to increase access to high-value medicines, driving growth.

Aptar Pharma working closely with Santen Pharmaceutical to improve patient safety, achieve dosing accuracy and maintain product integrity.

With the new structure, Lonza is positioned to leverage its innovation programs and technology platforms to create new solutions at the food-pharma convergence and in microbial control.

A superior alternative filter solution for manufacturing processes using resin-bonded filter cartridges.

WuXi STA will have exclusive access to BioLingus's novel platform to stabilize and deliver sublingually drug targets including small molecules, peptides and proteins, that are currently administered to patients via injection.

MedPharm and Palvella Therapeutics hope to develop the first approved treatment for PC in the US and Europe.

The approval enables Sirio to add special sports nutrition ingredients into products and covers six functional classes for ‘protein supplementary’, ‘speed & power’, ‘endurance’, ‘energy control’, ‘energy supplementary’, and ‘post-exercise recovery’.

The CDMO invested EUR 35 million into its operations and launched a 3-year programme to provide a compliant serialisation solution for its customers.

Collaboration provides drug discovery researchers access to European distribution and local support for library of in-stock and on-demand compounds.

The advanced candidate compound undergoing the trial has demonstrated potential to target malaria parasites before they have a chance to establish the symptoms of malaria.

Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.

Partner connectivity will be an immediate and ongoing challenge beyond the deadline and several pharma companies are likely to break agreements with current suppliers through breach of contract clauses.

Local competence in application and formulation technology for sub-Saharan African personal care market.

Cablivi is the first US approval for Sanofi's new rare blood disorders franchise.

Teething problems are no stranger to the implementation of new regulations, but with the EU FMD, Brexit came like a set of wisdom teeth – late, painful and problematic.

Awards showcased a wide range of industry-changing discoveries in drug delivery, packaging and automation.

The LyoConstellation series allows the development of highly aggressive cycles and the mapping of the furthest reaches of theoretical design space for a formulation.

Acquisition will strengthen Hitachi's presence in the second-largest cell and gene therapy market in the world.

Mylan's Wixela Inhub is the first FDA-approved therapeutically equivalent generic of Advair Diskus (fluticasone propionate and salmeterol inhalation powder) for certain patients with asthma or COPD.